Hap Trading, LLC Abb Vie Inc. Put Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Put Options

25 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $688,000 - $774,850	5,000 Added 17.73%	33,200 $178 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $1.18 Million - $1.36 Million	-8,800 Reduced 23.78%	28,200 $4.2 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $437,282 - $544,170	-3,300 Reduced 8.19%	37,000 $4.99 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $665,206 - $766,084	-4,600 Reduced 10.24%	40,300 $308,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $1.16 Million - $1.39 Million	-8,400 Reduced 15.76%	44,900 $358,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1.11 Million - $1.28 Million	8,300 Added 18.44%	53,300 $977,000
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $2.83 Million - $3.6 Million	-20,600 Reduced 31.4%	45,000 $616,000
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $1.33 Million - $1.65 Million	-10,100 Reduced 13.34%	65,600 $529,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $504,921 - $638,871	-4,700 Reduced 5.85%	75,700 $101,000
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $3.45 Million - $3.91 Million	32,400 Added 67.5%	80,400 $363,000
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $3.06 Million - $3.41 Million	-29,100 Reduced 37.74%	48,000 $172,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $4.24 Million - $4.66 Million	-41,416 Reduced 34.95%	77,100 $189,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $1.26 Million - $1.7 Million	15,600 Added 15.16%	118,516 $88,000
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $570,098 - $669,107	6,636 Added 6.89%	102,916 $345,000
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $1.75 Million - $2.34 Million	23,880 Added 32.98%	96,280 $292,000
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $1.86 Million - $2.83 Million	-28,900 Reduced 28.53%	72,400 $591,000
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $4.13 Million - $5.16 Million	57,200 Added 129.71%	101,300 $139,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $94,470 - $113,580	-1,500 Reduced 3.29%	44,100 $166,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $453,330 - $579,462	6,900 Added 17.83%	45,600 $196,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $1.87 Million - $2.21 Million	24,300 Added 168.75%	38,700 $151,000
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $249,119 - $307,232	3,200 Added 28.57%	14,400 $26,000
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $395,032 - $467,412	-4,400 Reduced 28.21%	11,200 $76,000
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $165,618 - $221,778	1,800 Added 13.04%	15,600 $169,000
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $26,868 - $29,462	-300 Reduced 2.13%	13,800 $4,000
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $984,884 - $1.26 Million	14,100	14,100 $21,000

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account